Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 108

Sort by

Sort Order Select

Journal Articles

Cerebrovascular Disease and Cognition in Adults with Sickle Cell Disease

Princess Ikemenogo, BS, MS, Taniya Varughese, MSOT, OTR/L, Allison L'Hotta, OTD, OTR/L, Kamilya Hunter, MHS, Anna Bauer, BA, Regina Abel, PhD, Allison A. King, MD MPH, PhD

Blood (2019) 134 (Supplement_1): 789.

https://doi.org/10.1182/blood-2019-127283

Published: 2019

Journal Articles

GRK6 Regulates the Hemostatic Response to Injury through Its Rate-Limiting Effects on GPCR Signaling in Platelets

Xi Chen, PhD, Shuchi Gupta, Matthew Cooper, Daniel Dehelian, Xuefei Zhao, Lawrence F. Brass, MD PhD, Ulhas P. Naik, PhD, Meghna Ulhas Naik, MS, Jeffrey Benovic, Peisong Ma, PhD

Blood (2019) 134 (Supplement_1): 3611.

https://doi.org/10.1182/blood-2019-129175

Published: 2019

Journal Articles

Plasma BDNF Levels Are Associated with Stroke in Children with SCD

Julia A. Drexelius, Celeste K. Kanne, BA, Huy D Tran, MD, Hyacinth I Hyacinth, MDPhDMPH, Vivien A. Sheehan, MD PhD

Blood (2019) 134 (Supplement_1): 3565.

https://doi.org/10.1182/blood-2019-131191

Published: 2019

Journal Articles

Hydroxyurea Therapy to Prevent Incident Stroke Among Children with Sickle Cell Anaemia in Jamaica: The Extend Trial

Angela Rankine-Mullings, MBBS, Marvin Ellsworth Reid, MB, BS, PhD, Deanne Soares, MBBS,DM Radiology, Carolyn Taylor-Bryan, MBBS, PhD BSc, DM, Margaret Wisdom-Phipps, RN, RM, Karen Aldred, MSc, Teresa Latham, MA, Jennifer Knight-Madden, MBBS, PhD, Lesley King, MBBS, MRCP, Asha Badaloo, PhD, Adam Lane, PhD, Robert J. Adams, MD MS, Russell E. Ware, MD PhD

Blood (2019) 134 (Supplement_1): 2269.

https://doi.org/10.1182/blood-2019-126781

Published: 2019

Journal Articles

Pretransplant Risk Factors for Calcineurin Inhibitor-Induced Encephalopathy and Limbic Encephalitis Following Allogeneic Hematopoietic Cell Transplantation

Nao Tanizawa, MD, Hideo Koh, MD PhD, Hiroshi Okamura, MD PhD, Koh Shiro, MD PhD, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MD PhD, Asao Hirose, MD PhD, Mika Nakamae, MD PhD, Yasuhiro Nakashima, MD PhD, Takahiko Nakane, MD PhD, Masayuki Hino, MD PhD, Hirohisa Nakamae, MD PhD

Blood (2019) 134 (Supplement_1): 4492.

https://doi.org/10.1182/blood-2019-124264

Published: 2019

Journal Articles

PD-1 Inhibitor Combined with Chemotherapy As a Salvage Therapy for Refractory DLBCL

Xin Li, Rui Zhang, Qing Li, Juan Mu, Yedi Pu, Yili Jiang, Qi Deng

Blood (2019) 134 (Supplement_1): 5357.

https://doi.org/10.1182/blood-2019-128035

Published: 2019

Journal Articles

Mapping Comorbidity in CLL: Impact on Prognostic Factors, Treatment Patterns and Causes of Death

Emelie Curovic Rotbain, MD, Carsten Utoft Niemann, MD PhD Ass. Prof, Klaus Rostgaard, MSc., Caspar Da Cunha-Bang, MD PhD, Henrik Hjalgrim, MD Dr.MD, Henrik Frederiksen, MD Prof

Blood (2019) 134 (Supplement_1): 4285.

https://doi.org/10.1182/blood-2019-122673

Published: 2019

Journal Articles

Monitoring Sickle Cell Disease Using Spectral-Domain Optic Coherence Tomography in Pediatric Patients

Jing Jin, MD PhD, Robin E Miller, MD

Blood (2019) 134 (Supplement_1): 994.

https://doi.org/10.1182/blood-2019-123138

Published: 2019

Journal Articles

The Survival of Transplant Ineligible Multiple Myeloma Patients Treated with Bortezomib-Based Chemotherapy Is Affected By the Patient Fitness

Ji Hyun Lee, MD PhD, Sung-Hyun Kim, MD PhD, Seok Jae Huh, Jae-Cheol Jo, MD PhD, Ho-Jin Shin, MD PhD, Won-Sik Lee, Yoojin Lee, MD PhD, Ho Sup Lee, MD

Blood (2018) 132 (Supplement 1): 3307.

https://doi.org/10.1182/blood-2018-99-119473

Published: 2018

Journal Articles

Cardiovascular Hospitalization in Patients Treated with Dasatinib or Nilotinib in Simplicity, an Observational Study of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients in Routine Clinical Practice

Michael J. Mauro, MD, Clara Chen, PhD BS, MS, Jorge E. Cortes, MD, Carlo Gambacorti-Passerini, MD, Ginny P Sen, MPH, Srikanth Gajavelli, MD, Catherine Davis, Mauricette Michallet, MD PhD

Blood (2018) 132 (Supplement 1): 4258.

https://doi.org/10.1182/blood-2018-99-115903

Published: 2018

Journal Articles

Relationship between Hemolytic Index Early in Life with Development of Abnormal Transcranial Doppler Velocities in Pediatric Patients with Sickle Cell Anemia

Derrick L Goubeaux, DO, Ashley Sherman, MA, Ram Kalpatthi, MD, Gerald Woods

Blood (2018) 132 (Supplement 1): 2382.

https://doi.org/10.1182/blood-2018-99-112470

Published: 2018

Journal Articles

Cerebral Infarcts and Cerebrovascular Disease in Neurologically Intact Tanzanian Children with Sickle Cell Anaemia

Mboka Mwakatika Mwakatika, MD, Dawn E Saunders, MD, Julie Makani, MD PhD FRCP, Fenella Jane Kirkham, MD

Blood (2018) 132 (Supplement 1): 1089.

https://doi.org/10.1182/blood-2018-99-119056

Published: 2018

Journal Articles

The Related Factors and the Prognosis of Nervous System Complications on the Pediatric Patients with Hematopoietic Stem Cell Transplantation

Suxiang Liu, MD, Defei Zheng, MD, Peifang Xiao, MD, Yi Wang, MD, Zong Zhai, MD, Jun Lu, MD, Jie Li, MD, Shaoyan Hu, MD PhD

Blood (2018) 132 (Supplement 1): 5718.

https://doi.org/10.1182/blood-2018-99-117803

Published: 2018

Journal Articles

Real-World Occurrence of Symptoms and Toxicities and Associated Cost Implications in Acute Myeloid Leukemia (AML) Treatment Episodes: A Retrospective Database Analysis in the US

Bhavik J Pandya, PharmD, Bruno C Medeiros, MD, Chi-Chang Chen, PhD, Samuel Wilson, PhD, Eric S. Groves, MD PhD, Laura Elise Horvath, MD, Rolin L. Wade, RpH, MS

Blood (2017) 130 (Supplement 1): 2118.

https://doi.org/10.1182/blood.V130.Suppl_1.2118.2118

Published: 2017

Journal Articles

Cerebrovascular Disease after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Manifestations, Risk and Clinical Outcome

Yao-Chung LIU, MD, Ting-An Lin, MD, Po-Shen Ko, MD, Hao-Yuan Wang, MD, Sheng-Hsuan Chien, MD, Chia-Jen Liu, MD PhD, Tzeon-Jye Chiou, MD, Liang-Tsai Hsiao, MD, Jyh-Pyng Gau, MD, Jin-Hwang Liu, MD PhD

Blood (2017) 130 (Supplement 1): 4527.

https://doi.org/10.1182/blood.V130.Suppl_1.4527.4527

Published: 2017

Journal Articles

Atherosclerotic Arterial Disease-Related Mortality in Chronic Myeloid Patients Treated with Tyrosine Kinase Inhibitors

Remco J Molenaar, Tomas Radivoyevitch, Aziz Nazha, MD, Anjali S. Advani, MD, Aaron T. Gerds, MDMS, Jaroslaw P. Maciejewski, PhD MD FACP, Navneet S. Majhail, MD MS, Mikkael A. Sekeres, MD MS, Matt Kalaycio, MD, Sudipto Mukherjee, MD PhD MPH

Blood (2017) 130 (Supplement 1): 2871.

https://doi.org/10.1182/blood.V130.Suppl_1.2871.2871

Published: 2017

Journal Articles

Increased Volume and Distinct Pattern of Silent Cerebral Infarcts in Healthy, Young Adults with Sickle Cell Trait

Andria L Ford, MD, Melanie E Fields, MD, Kristin P Guilliams, MD MSc, Dustin K Ragan, PhD, Chen Yasheng, DSc, Georges Guillaume, Joshua S Shimony, MD PhD, Katie D Vo, MD, Morey Blinder, MD, Allison King, MDMPH,PhD, Monica L Hulbert, MD, Robert C McKinstry, MD PhD, Hongyu An, DSc

Blood (2017) 130 (Supplement 1): 757.

https://doi.org/10.1182/blood.V130.Suppl_1.757.757

Published: 2017

Journal Articles

Distribution and Impact of Comorbidities on Survival and Leukemic Transformation in Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis (MF)

Justyna Bartoszko, MD, Tony Panzarella, BSc MSc, Caroline Jane McNamara, MBBS, Anthea Lau, Aaron D. Schimmer, MD PhD, Andre C. Schuh, MD FRCPC, Hassan Sibai, MD, Karen W.L. Yee, MD, Mark D. Minden, MD PhD, Rebecca Devlin, PhD, Vikas Gupta, MD

Blood (2016) 128 (22): 4264.

https://doi.org/10.1182/blood.V128.22.4264.4264

Published: 2016

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Patients with Myelodysplastic Syndromes

Bartlomiej Getta, MBBS,, Ashwin Kishtagari, MD, Patrick Hilden, MS, Sean Devlin, PhD, Molly A. Maloy, MS, Patrick K. Gonzales, Brian C. Shaffer, MD, Doris M Ponce, MD, Boglarka Gyurkocza, MD, Juliet N. Barker, MBBS, Esperanza B. Papadopoulos, MD, Hugo Castro-Malaspina, MD, Ann A. Jakubowski, MD PhD, James W. Young, MD, Martin S. Tallman, MD, Miguel-Angel Perales, MD, Sergio A. Giralt, MD, Roni Tamari, MD, Virginia M. Klimek, MD

Blood (2016) 128 (22): 3188.

https://doi.org/10.1182/blood.V128.22.3188.3188

Published: 2016

Journal Articles

Validation of a Modified Comorbidity Index for Allogeneic Hematopoietic Cell Transplant

Todd E. DeFor, MS, Chap Le, PhD, Angela R Smith, MD MS, Erica D. Warlick, MD, Nelli Bejanyan, MD, Daniel J. Weisdorf, MD

Blood (2016) 128 (22): 1167.

https://doi.org/10.1182/blood.V128.22.1167.1167

Published: 2016

NARROW

Cerebrovascular Disease and Cognition in Adults with Sickle Cell Disease

GRK6 Regulates the Hemostatic Response to Injury through Its Rate-Limiting Effects on GPCR Signaling in Platelets

Plasma BDNF Levels Are Associated with Stroke in Children with SCD

Hydroxyurea Therapy to Prevent Incident Stroke Among Children with Sickle Cell Anaemia in Jamaica: The Extend Trial

Pretransplant Risk Factors for Calcineurin Inhibitor-Induced Encephalopathy and Limbic Encephalitis Following Allogeneic Hematopoietic Cell Transplantation

PD-1 Inhibitor Combined with Chemotherapy As a Salvage Therapy for Refractory DLBCL

Mapping Comorbidity in CLL: Impact on Prognostic Factors, Treatment Patterns and Causes of Death

Monitoring Sickle Cell Disease Using Spectral-Domain Optic Coherence Tomography in Pediatric Patients

The Survival of Transplant Ineligible Multiple Myeloma Patients Treated with Bortezomib-Based Chemotherapy Is Affected By the Patient Fitness

Cardiovascular Hospitalization in Patients Treated with Dasatinib or Nilotinib in Simplicity, an Observational Study of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients in Routine Clinical Practice

Relationship between Hemolytic Index Early in Life with Development of Abnormal Transcranial Doppler Velocities in Pediatric Patients with Sickle Cell Anemia

Cerebral Infarcts and Cerebrovascular Disease in Neurologically Intact Tanzanian Children with Sickle Cell Anaemia

The Related Factors and the Prognosis of Nervous System Complications on the Pediatric Patients with Hematopoietic Stem Cell Transplantation

Real-World Occurrence of Symptoms and Toxicities and Associated Cost Implications in Acute Myeloid Leukemia (AML) Treatment Episodes: A Retrospective Database Analysis in the US

Cerebrovascular Disease after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Manifestations, Risk and Clinical Outcome

Atherosclerotic Arterial Disease-Related Mortality in Chronic Myeloid Patients Treated with Tyrosine Kinase Inhibitors

Increased Volume and Distinct Pattern of Silent Cerebral Infarcts in Healthy, Young Adults with Sickle Cell Trait

Distribution and Impact of Comorbidities on Survival and Leukemic Transformation in Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis (MF)

Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Patients with Myelodysplastic Syndromes

Validation of a Modified Comorbidity Index for Allogeneic Hematopoietic Cell Transplant

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only